Topics:
Breast Cancer • Gastrointestinal Cancers • Medical Oncology • Multiple sclerosis • Neuropathy • Chemotherapy • Neurology
How do you manage neuropathic chemotherapy agents in patients with underlying multiple sclerosis?
Are there contraindications to drugs like oxaliplatin or abraxane?
Does chronicity or severity of the patient's underlying symptoms play a role in your decision?
Answer from: at Academic Institution
I would make sure that if they do have B and T cell immunosuppressive effects (I would check their FDA access data records, phase 3 clinical trials, other drug sites that detail their MOA) and I am convinced that my MS drugs (if the patient is on any) are not needed, I would discontinue such therapy...
Sign in or Register to read more